We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-1.78%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.24%
AUM
$25.4B
AUM Growth
-$3.97B
(-14%)
Cap. Flow
-$2.52B
Cap. Flow
% of AUM
-9.92%
Top 10 Holdings %
Top 10 Hldgs %
35.93%
Holding
2,661
New
162
Increased
692
Reduced
916
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$258M |
| 2 |
VICI Properties
VICI
|
+$225M |
| 3 |
Eli Lilly
LLY
|
+$197M |
| 4 |
ExxonMobil
XOM
|
+$159M |
| 5 |
Booking.com
BKNG
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$523M |
| 2 |
Gilead Sciences
GILD
|
+$433M |
| 3 |
Merck
MRK
|
+$429M |
| 4 |
Apple
AAPL
|
+$303M |
| 5 |
Corning
GLW
|
+$287M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.53% |
| 2 | Financials | 11.8% |
| 3 | Healthcare | 10.63% |
| 4 | Communication Services | 9.23% |
| 5 | Consumer Discretionary | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
FB Financial Corp
FBK
$2.94B
| $426K | ﹤0.01% |
8,196
-691
| -8% | -$38.8K |
|
|
AEBI
927
Aebi Schmidt Holding AG
AEBI
$1.01B
| $422K | ﹤0.01% |
43,486
+13,219
| +44% | +$181K |
|
|
TERN
928
DELISTED
Terns Pharmaceuticals
TERN
| $421K | ﹤0.01% |
+7,994
| New | +$328K |
|
929
FerroAtlántica
GSM
$615M
| $421K | ﹤0.01% |
102,170
+28,610
| +39% | +$138K |
|
930
Magnite
MGNI
$2.77B
| $420K | ﹤0.01% |
35,325
-4,759
| -12% | -$63.8K |
|
931
Monte Rosa Therapeutics
GLUE
$1.92B
| $417K | ﹤0.01% |
25,331
-1,475
| -6% | -$28.2K |
|
932
Schrodinger
SDGR
$1.13B
| $416K | ﹤0.01% |
36,606
+35,148
| +2,411% | +$486K |
|
933
Otter Tail
OTTR
$3.85B
| $414K | ﹤0.01% |
4,714
-7,846
| -62% | -$679K |
|
934
Boston Scientific
BSX
$68.5B
| $413K | ﹤0.01% |
6,588
-429,595
| -98% | -$34.4M |
|
935
Lightbridge
LTBR
$257M
| $412K | ﹤0.01% |
+38,695
| New | +$538K |
|
936
Willdan Group
WLDN
$1.1B
| $411K | ﹤0.01% |
5,373
-10,244
| -66% | -$1.08M |
|
937
Neuropace
NPCE
$522M
| $408K | ﹤0.01% |
30,993
+4,178
| +16% | +$62.7K |
|
938
Mondelez International
MDLZ
$77.9B
| $404K | ﹤0.01% |
7,002
-163
| -2% | -$9.44K |
|
|
LIF
939
Life360
LIF
$4.32B
| $403K | ﹤0.01% |
9,875
+785
| +9% | +$40.6K |
|
940
Simon Property Group
SPG
$74.7B
| $402K | ﹤0.01% |
+2,157
| New | +$411K |
|
941
Frontdoor
FTDR
$5.1B
| $400K | ﹤0.01% |
7,569
-29,853
| -80% | -$1.78M |
|
942
Mammoth Energy Services
TUSK
$130M
| $400K | ﹤0.01% |
+163,259
| New | +$372K |
|
943
ArriVent BioPharma
AVBP
$1.45B
| $399K | ﹤0.01% |
17,308
-22,992
| -57% | -$519K |
|
|
SILA
944
DELISTED
Sila Realty Trust
SILA
| $399K | ﹤0.01% |
16,859
| – | – |
|
945
Clearfield
CLFD
$417M
| $397K | ﹤0.01% |
15,002
+12,840
| +594% | +$391K |
|
946
Pediatrix Medical
MD
$2.17B
| $397K | ﹤0.01% |
18,539
+16,537
| +826% | +$344K |
|
947
Kymera Therapeutics
KYMR
$9.14B
| $394K | ﹤0.01% |
4,730
+2,762
| +140% | +$219K |
|
948
Myriad Genetics
MYGN
$528M
| $392K | ﹤0.01% |
87,180
-10,239
| -11% | -$53.3K |
|
949
Encore Capital Group
ECPG
$1.98B
| $391K | ﹤0.01% |
5,574
-4,659
| -46% | -$286K |
|
950
Great Southern Bancorp
GSBC
$866M
| $389K | ﹤0.01% |
6,158
+186
| +3% | +$11.6K |
|
Similar funds
KK
VAI
SO
UIM
Los Angeles Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Los Angeles Capital Management held 2,661 positions worth $25.4B, down 14% from $29.3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Los Angeles Capital Management withdrew a net $2.52B in Q1 2026, closing 287 positions and reducing 916 holdings. Its most notable exit was Exact Sciences, an estimated $9.68M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 41% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Los Angeles Capital Management opened a new position in VICI Properties worth $215M.
- Los Angeles Capital Management's largest Q1 2026 buy was VICI Properties: 7,871,258 shares worth $215M.
- Los Angeles Capital Management added most to AT&T in Q1 2026, an estimated $258M increase.
- Los Angeles Capital Management's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $523M.
- Los Angeles Capital Management fully exited Exact Sciences in Q1 2026, selling an estimated $9.68M.
- Los Angeles Capital Management's ten largest holdings make up 36% of its $25.4B portfolio in Q1 2026.
- Los Angeles Capital Management opened 162 new positions and closed 287 in Q1 2026.
- Los Angeles Capital Management's portfolio value fell 14% quarter-over-quarter to $25.4B.
Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.